Piroxicam in the treatment of acute gout: a multicentre open study in general practice

J Int Med Res. 1979;7(6):507-10. doi: 10.1177/030006057900700605.

Abstract

Twenty-nine patients with acute gout were treated with piroxicam (40 mg daily for 5 days) in a multicentre general practitioner study. Pain relief was noticeable within 4 hours of the first dose and thereafter proceeded steadily, together with the early relief of other symptoms associated with acute gout. The prompt relief of symptoms was accompanied by a fall in serum uric acid. Piroxicam was well tolerated, eight experiencing side-effects that were mainly mild and gastro-intestinal in nature. The drug seems to be highly effective and safe in the treatment of acute gout.

MeSH terms

  • Acute Disease
  • Adult
  • Aged
  • Female
  • Gout / drug therapy*
  • Gout Suppressants / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Pyridines / therapeutic use*
  • Thiazines / therapeutic use*
  • Uric Acid / blood

Substances

  • Gout Suppressants
  • Pyridines
  • Thiazines
  • Uric Acid